Brief: Quotient Limited Provides Update On Mosaiq Expanded Immunohematology Microarray CE Marking Progress
Dec 15 (Reuters) - Quotient Ltd QTNT.O :
* QUOTIENT LIMITED PROVIDES UPDATE ON MOSAIQ EXPANDED IMMUNOHEMATOLOGY
MICROARRAY
CE MARKING PROGRESS
* QUOTIENT LTD - RECEIVED FEEDBACK FROM EUROPEAN NOTIFIED BODY AFTER REVIEW
OF
EXPANDED IH SUBMISSION
* QUOTIENT LTD - CONTINUE TO EXPECT APPROVAL IN Q1 CY 2022
* QUOTIENT LTD - PLEASED WITH FEEDBACK AND EXPECT TO SUBMIT A RESPONSE TO
QUESTIONS IN NEXT COUPLE OF WEEKS
Source text for Eikon: ID:nGNX30rlbz
Further company coverage: QTNT.O
Recent news on Quotient
See all newsBrief: Quotient Ltd Enters Into Amended And Restated Transaction Support Agreement
U.S. STOCKS ON THE MOVE-Tesla, Exxon Mobil, Chevron
Quotient down on plans to delist from Nasdaq
Brief: Quotient Limited Announces Intent To Voluntary Delist From The Nasdaq Global Market
U.S. STOCKS ON THE MOVE-Organon, Veracyte, InfuSystem